Status:

COMPLETED

Impact of 2.0g Daily of MAG-EPA on the AA/EPA Ratio and Inflammation Biomarkers in a Healthy Population Aged of 50+.

Lead Sponsor:

SCF Pharma

Collaborating Sponsors:

Integrated Health and Social Services Centres (CISSS) de la Gaspésie

Integrated Health and Social Services Centres (CISSS) du Bas-St-Laurent

Conditions:

Inflammation

Eligibility:

All Genders

50+ years

Phase:

PHASE4

Brief Summary

According to scientific literature, oils containing omega-3 fatty acids may decrease certain risk factors for cardiovascular disease such as blood pressure, blood level of triglycerides (TGs) and chol...

Detailed Description

This pilot study aims to determine the average value of the ratio of arachidonic to eicosapentaenoic acids (AA/EPA) in a population aged 50 and over without any particular medical condition when suppl...

Eligibility Criteria

Inclusion

  • Participant aged 50 or over.
  • Available for the entire duration of the study and willing to participate based on the information provided in the ICF duly read and signed by the latter.
  • Participant not presenting any intellectual problems likely to limit the validity of the consent to participate in the study and the respect of protocol requirements, having the capacity to cooperate adequately, to understand and to follow the instructions of the doctor or his delegates.
  • Participant who has no difficulty swallowing tablets or capsules.

Exclusion

  • Known allergy or intolerance to fish or history of allergic reactions attributable to fish, or to a compound similar to fish oil.
  • Pregnant or breastfeeding woman.
  • Participant who used omega-3 supplements within 60 days of study day 1.
  • Difficulty obtaining blood samples by capillary or venous puncture at the time of selection.

Key Trial Info

Start Date :

April 21 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 14 2023

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04897893

Start Date

April 21 2021

End Date

September 14 2023

Last Update

November 27 2023

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

SCF Pharma

Maria, Quebec, Canada, G0C 1Y0

2

SCF Pharma

Rimouski, Quebec, Canada, G0K 1P0